SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+5.62%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$652M
AUM Growth
+$652M
(+64%)
Cap. Flow
+$238M
Cap. Flow
% of AUM
36.52%
Top 10 Holdings %
Top 10 Hldgs %
43.69%
Holding
147
New
54
Increased
27
Reduced
34
Closed
24
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$29.5M |
| 2 |
AbbVie
ABBV
|
$23.3M |
| 3 |
ISRL
Isramco Inc
ISRL
|
$22.1M |
| 4 |
Pfizer
PFE
|
$18.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$16.8M |
Top Sells
| 1 |
Sanofi
SNY
|
$12.7M |
| 2 |
GSK
GSK
|
$9.33M |
| 3 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$8.94M |
| 4 |
Biogen
BIIB
|
$6.94M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$5.3M |
Sector Composition
| 1 | Healthcare | 70.86% |
| 2 | Technology | 5.53% |
| 3 | Energy | 3.84% |
| 4 | Industrials | 3.33% |
| 5 | Materials | 1.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
VF Corp
VFC
$5.79B
| $3.16M | 0.39% |
+47,900
| New | +$3.16M |
|
|
RDUS
52
DELISTED
Radius Health, Inc.
RDUS
| $3.15M | 0.39% |
+150,000
| New | +$3.15M |
|
|
SLXP
53
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $3.13M | 0.39% |
+20,000
| New | +$3.13M |
|
54
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $3.12M | 0.39% |
48,853
+19,500
| +66% | +$1.25M |
|
|
ARRY
55
DELISTED
Array Biopharma Inc
ARRY
| $3.12M | 0.39% |
873,922
+588,922
| +207% | +$2.1M |
|
|
XLRN
56
DELISTED
Acceleron Pharma Inc.
XLRN
| $3.02M | 0.37% |
+100,000
| New | +$3.02M |
|
57
Incyte
INCY
$17B
| $3M | 0.37% |
61,173
-11,827
| -16% | -$580K |
|
|
AVNR
58
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $2.98M | 0.37% |
250,000
-750,000
| -75% | -$8.94M |
|
59
Schlumberger
SLB
$52.2B
| $2.93M | 0.36% |
+28,790
| New | +$2.93M |
|
60
Yum! Brands
YUM
$40.1B
| $2.87M | 0.35% |
39,910
-16,523
| -29% | -$1.19M |
|
61
PTC Therapeutics
PTCT
$4.41B
| $2.8M | 0.35% |
63,625
-86,375
| -58% | -$3.8M |
|
|
TW
62
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $2.79M | 0.34% |
28,000
-13,740
| -33% | -$1.37M |
|
|
SAGE
63
DELISTED
Sage Therapeutics
SAGE
| $2.77M | 0.34% |
+87,924
| New | +$2.77M |
|
|
OTIC
64
DELISTED
Otonomy, Inc.
OTIC
| $2.67M | 0.33% |
+111,085
| New | +$2.67M |
|
65
Nice
NICE
$8.48B
| $2.62M | 0.32% |
+64,542
| New | +$2.62M |
|
66
Colgate-Palmolive
CL
$67.7B
| $2.62M | 0.32% |
40,099
-7,700
| -16% | -$502K |
|
67
Ironwood Pharmaceuticals
IRWD
$201M
| $2.52M | 0.31% |
+194,200
| New | +$2.52M |
|
68
Catalyst Pharmaceutical
CPRX
$2.42B
| $2.28M | 0.28% |
+685,500
| New | +$2.28M |
|
69
Vanda Pharmaceuticals
VNDA
$279M
| $2.27M | 0.28% |
218,390
+78,390
| +56% | +$814K |
|
70
MacroGenics
MGNX
$121M
| $2.25M | 0.28% |
107,781
-3,219
| -3% | -$67.3K |
|
|
LJPC
71
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.15M | 0.27% |
+223,330
| New | +$2.15M |
|
|
TRVN
72
DELISTED
Trevena, Inc.
TRVN
| $2.13M | 0.26% |
331,111
-9,889
| -3% | -$64.2K |
|
|
ARNA
73
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.1M | 0.26% |
+500,000
| New | +$2.1M |
|
|
RLYP
74
DELISTED
RELYPSA INC COM
RLYP
| $2.05M | 0.25% |
+97,100
| New | +$2.05M |
|
75
Akebia Therapeutics
AKBA
$827M
| $1.99M | 0.25% |
89,817
+17,317
| +24% | +$383K |
|